1. Home
  2. TECH vs NML Comparison

TECH vs NML Comparison

Compare TECH & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • NML
  • Stock Information
  • Founded
  • TECH 1976
  • NML 2012
  • Country
  • TECH United States
  • NML United States
  • Employees
  • TECH N/A
  • NML N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • NML Finance/Investors Services
  • Sector
  • TECH Health Care
  • NML Finance
  • Exchange
  • TECH Nasdaq
  • NML Nasdaq
  • Market Cap
  • TECH 8.0B
  • NML 454.4M
  • IPO Year
  • TECH 1989
  • NML N/A
  • Fundamental
  • Price
  • TECH $48.10
  • NML $8.36
  • Analyst Decision
  • TECH Buy
  • NML
  • Analyst Count
  • TECH 9
  • NML 0
  • Target Price
  • TECH $81.25
  • NML N/A
  • AVG Volume (30 Days)
  • TECH 2.2M
  • NML 219.3K
  • Earning Date
  • TECH 05-07-2025
  • NML 01-01-0001
  • Dividend Yield
  • TECH 0.63%
  • NML 9.75%
  • EPS Growth
  • TECH N/A
  • NML N/A
  • EPS
  • TECH 0.98
  • NML N/A
  • Revenue
  • TECH $1,196,016,000.00
  • NML N/A
  • Revenue This Year
  • TECH $8.19
  • NML N/A
  • Revenue Next Year
  • TECH $8.85
  • NML N/A
  • P/E Ratio
  • TECH $49.09
  • NML N/A
  • Revenue Growth
  • TECH 4.46
  • NML N/A
  • 52 Week Low
  • TECH $46.44
  • NML $6.09
  • 52 Week High
  • TECH $85.57
  • NML $7.33
  • Technical
  • Relative Strength Index (RSI)
  • TECH 33.97
  • NML 46.19
  • Support Level
  • TECH $46.44
  • NML $7.70
  • Resistance Level
  • TECH $53.00
  • NML $8.42
  • Average True Range (ATR)
  • TECH 3.30
  • NML 0.41
  • MACD
  • TECH -0.27
  • NML -0.02
  • Stochastic Oscillator
  • TECH 13.00
  • NML 58.88

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.

Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.

Share on Social Networks: